Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/ml500278g http://scihub22266oqcxt.onion/10.1021/ml500278g C4190624!4190624 !25313325     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25313325 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       ACS+Med+Chem+Lett 2014 ; 5 (10 ): 1129-32 Nephropedia Template TP {{tp|p=25313325 |t=2014. Saralasin and Sarile Are AT2 Receptor Agonists |pdf=|usr=}}{{25313325 }} gab.com Text Saralasin and Sarile Are AT2 Receptor Agonists JO: ACS Med Chem Lett http://www.kidney.de/pget.php?&tw=1&pmid=25313325 #FOAvip Saralasin and sarile, extensively studied over the past 40 years as angiotensin II (Ang II) receptor blockers, induce neurite outgrowth in a NG108-15 cell assay to a similar extent as the endogenous Ang II. In their undifferentiated state, these cells express mainly the AT2 receptor. The neurite outgrowth was inhibited by preincubation with the AT2 receptor selective antagonist PD 123,319, which suggests that the observed outgrowth was mediated by the AT2 receptor. Neither saralasin nor sarile reduced the neurite outgrowth induced by Ang II proving that the two octapeptides do not act as antagonists at the AT2 receptor and may be considered as AT2 receptor agonists. Twit Text FOAVip Saralasin and Sarile Are AT2 Receptor Agonists ????ACS Med Chem Lett http://www.kidney.de/pget.php?&tw=1&pmid=25313325 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25313325 #FOAvip English Wikipedia <ref>{{Cite pmid|25313325 }}</ref> Saralasin and Sarile Are AT2 Receptor Agonists #MMPMID25313325 Guimond MO ; Hallberg M ; Gallo-Payet N ; Wallinder C ACS Med Chem Lett 2014[Oct]; 5 (10 ): 1129-32 PMID25313325 show ga Saralasin and sarile, extensively studied over the past 40 years as angiotensin II (Ang II) receptor blockers, induce neurite outgrowth in a NG108-15 cell assay to a similar extent as the endogenous Ang II. In their undifferentiated state, these cells express mainly the AT2 receptor. The neurite outgrowth was inhibited by preincubation with the AT2 receptor selective antagonist PD 123,319, which suggests that the observed outgrowth was mediated by the AT2 receptor. Neither saralasin nor sarile reduced the neurite outgrowth induced by Ang II proving that the two octapeptides do not act as antagonists at the AT2 receptor and may be considered as AT2 receptor agonists. äSaralasin and Sarile Are AT2 Receptor Agonists (epmc).pdf DeepDyve Pubget Overpricing